Nora Alvarez Agila, MD, a radio-oncologist from the National Cancer Institute of Mexico, is Visiting Scientist with the Harvard Global Equity Initiative. Dr. Alvarez will be involved on research to improve quality of cancer care and increase access to care among low-income populations.
Former editor-in-chief of the New England Journal of Medicine, Dr. Angell is widely recognized as a national leader in areas of health policy and medical ethics. In the Department of Global Health and Social Medicine, she is a key contributor to Division of Medical Ethics programs and planning. Her primary responsibility is to organize and moderate the Faculty Seminar Series, which attracts health care professionals from across the University and affiliated hospitals to monthly presentations and discussions.
Ankur Asthana is an associate in Global Health and Social Medicine at the Department of Global Health and Social Medicine at Harvard Medical School where he studies models for global health policy change, grassroots advocacy, and health delivery activism. He is the co-founder and co-executive director of Article 25, a peoples movement for the right to health of more than 15,000 activists across 65 countries.
Research Fellow in Global Health and Social Medicine (EXT)
Former community health worker with PACT, Devin Atallah, PhD, joined the Department as a Research Fellow. He will develop his recently completed dissertation on Palestinian communities living in refugee camps into a book that would inform mental health interventions and policy decisions related to supporting communities that have experienced trauma. Mary-Jo Good is mentoring Devin.
Professor in the Dept of Global Health and Population
My research focuses on HIV in impoverished populations. In 1996, I launched a series of studies in HIV+ homeless and marginally housed individuals in response to concerns that poor adherence to HIV antiretroviral treatment in the urban poor would create new strains of drug resistant virus. I described the challenges in providing antiretroviral therapy to the urban poor, developed valid measures of adherence, defined the risk of antiretroviral resistance by level of adherence, and developed effective interventions to improve adherence in the HIV+ urban poor.
Currently on secondment with the World Bank Group, Dr. Bayona is the director of global health programs and practice for the Dartmouth Center for Health Care Delivery Science. He joined Dartmouth from Peru, where he was the co-founder and director of Socios En Salud Sucursal Peru (SES), the Peruvian branch of Partners In Health (PIH). At SES, Dr.